Individual InvestorsEmployee Shareholders Institutional InvestorsPrivate Companies Accredited InvestorsSeed & Angel InvestorsAsset Managers & Hedge FundsFamily OfficesVenture Capital FirmsWealth Managers & RIAsWho We Serve Trading Data Liquidity Programs Retirement Institutional TradingForge ProTrade private companies with Forge’s institutional brokerage tool​Browse CompaniesIndividual InvestingForge MarketsFind new private company investment opportunities​Forge PriceA proprietary indicative price, calculated daily, for approximately 200 pre-IPO companiesForge DataAnalyze private markets via Forge’s intuitive web application​Forge Private Market Index​Monitor a benchmark for actively traded private companies ​Forge Accuidity Private Market Index​Invest in an institutionally-managed diversified basket of private companies (QPs only)​Liquidity ProgramsRetain and reward employees with company-sponsored liquidity solutions like tender offers and customized programsSelf-Directed IRAForge TrustInvest in private companies and other alternative assets through a tax-advantaged Self-Directed IRAWhat We Do All Insights Private Market Reports Market Insights Buying and Selling Pre-IPO​ All Reports​Private Market UpdatesForge Investment OutlookStartup News and Trends​Private Market Data and Analytics​Tech IPO Calendar for 2025Magnificent 7Private Market Explained​Buying Pre-IPO Shares​Selling Pre-IPO SharesGlossaryVideosFAQsInsights About UsLeadershipInvestor RelationsPeople & CultureCareers About
Log InSign Up
Who We Serve
What We Do
Insights
About
RayzeBio

RayzeBio IPO

$599.64MM
Series D Valuation, Sep 2022
Register for Details
For more details on financing and valuation of private companies similar to RayzeBio before its , register or login today.
Please provide a valid email address.
By registering, you agree to Forge’s Terms of Use. Already registered? Sign in
Company Details
RayzeBio develops novel peptide mimetic binders to deliver potent therapeutic radioisotopes such as Actinium-225, an alpha-emitter. RayzeBio was founded in 2020 by Kathie Huynh and is headquartered in San Diego, CA.
Founded
2020
Headquarters
San Diego, CA, United States
Forge Price 1
Price not available
Post-Money Valuation 3
$599.64MM
Total Funding
$795.51MM
LFR Price per Share
$xx.xx
Last Funding Share Class
Series D

Learn More About RayzeBio

To invest in RayzeBio pre-IPO

Can you invest in RayzeBio pre-IPO?

You can no longer invest in RayzeBio with Forge. But if you are an accredited investor interested in buying pre-IPO shares of a private company, you can learn more about how to invest in the private market or register today to get started.

Can you sell shares of RayzeBio before it goes public?

You can no longer sell shares of RayzeBio on Forge as this company is no longer private. However, if you own shares of a private company, Forge may be able to help you sell them in a way that works for you and the company. Learn more or register with us today to get started.

What is the pre-IPO value of my RayzeBio shares?

Forge can no longer determine the value of RayzeBio shares as this company is no longer private. However, if you own shares of a private company, Forge may help you value and sell them in a way that works for you and the company. Learn more or register with us today to get started.

Is RayzeBio a publicly traded company?

RayzeBio became a public company following its M&A on 12/26/2023 and is now a publicly traded company.

To learn more about RayzeBio potential IPO

Will RayzeBio go IPO?

RayzeBio became a public company following its M&A on 12/26/2023.

What is RayzeBio’s IPO price?

The IPO price of RayzeBio is not currently available.

When was RayzeBio founded?

RayzeBio was founded in 2020.

What is RayzeBio funding to date?

RayzeBio has raised $795.51MM to date.
RayzeBio Major Investors
Versant Ventures
Venbio
Laurion Capital Management
Deerfield Management
Venbio Partners
Venrock Healthcare Capital Partners
Cormorant Asset Management
Orbimed
Venrock
Wellington Management
Ally Bridge Group
Vivo Capital
Redmile Group
Perceptive Advisors
Soleus Capital
Sands Capital Ventures
Sands Capital
Tcg
Acuta Capital Partners
Logos Capital
Samsara Biocapital
Viking
Sofinnova Investments
Viking Global Investors
Cg X
Alexandria Venture Investments
Lifesci Venture Partners
Orbimed Advisors

RayzeBio Funding Rounds and Valuation

Funding History Chart
Funding Round Details
Funding Date Share Class Amount Raised Price per Share Post-Money Valuation Key Investors
09/13/2022 Series D $159.75MM $xx.xx $599.64MM Ally Bridge Group, Laurion Capital Management, Sands Capital, Sofinnova Investments, Soleus Capital, Viking Global Investors, Wellington Management
Price per Share
$xx.xx
Shares Outstanding
63,972,982
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Ally Bridge Group, Laurion Capital Management, Sands Capital, Sofinnova Investments, Soleus Capital, Viking Global Investors, Wellington Management
06/15/2021 Series C $99.63MM $xx.xx $651.39MM Acuta Capital Partners, Alexandria Venture Investments, Cg X, Cormorant Asset Management, Deerfield Management, Lifesci Venture Partners, Logos Capital, Orbimed, Perceptive Advisors, Redmile Group, Samsara Biocapital, Venbio Partners, Venrock Healthcare Capital Partners, Versant Ventures, Viking Global Investors, Vivo Capital
Price per Share
$xx.xx
Shares Outstanding
23,999,996
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.1x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Acuta Capital Partners, Alexandria Venture Investments, Cg X, Cormorant Asset Management, Deerfield Management, Lifesci Venture Partners, Logos Capital, Orbimed, Perceptive Advisors, Redmile Group, Samsara Biocapital, Venbio Partners, Venrock Healthcare Capital Partners, Versant Ventures, Viking Global Investors, Vivo Capital
12/08/2020 Series B $96.86MM $xx.xx $237.83MM Alexandria Venture Investments, Cormorant Asset Management, Lifesci Venture Partners, Logos Capital, Orbimed, Redmile Group, Samsara Biocapital, Venbio Partners, Venrock Healthcare Capital Partners, Versant Ventures, Viking Global Investors
Price per Share
$xx.xx
Shares Outstanding
46,666,672
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Alexandria Venture Investments, Cormorant Asset Management, Lifesci Venture Partners, Logos Capital, Orbimed, Redmile Group, Samsara Biocapital, Venbio Partners, Venrock Healthcare Capital Partners, Versant Ventures, Viking Global Investors
10/14/2020 Series A $41.51MM $xx.xx $55.35MM Samsara Biocapital, Venbio Partners, Versant Ventures
Price per Share
$xx.xx
Shares Outstanding
45,000,000
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Samsara Biocapital, Venbio Partners, Versant Ventures
Private Companies Exploring an IPO
Last Funding Round
Company Forge Price Forge Price Change 5 Last Closed Trade Share Class Post-Money Valuation Price per Share Amount Raised
AndurilAnduril$42.52+42.78%$xx.xxSeries F$14B$xx.xx$1.12B
CoreWeaveCoreWeave$1,000.00-16.67%$xx.xxSeries C$19B$xx.xx$1.15B
CerebrasCerebras$34.64-5.15%$xx.xxSeries F-1$2.87B$xx.xx$420MM
KlarnaKlarna$447.67+20.99%$xx.xxUnknown------
CohesityCohesity$15.67+0.06%$xx.xxSeries H-1$4.69B$xx.xx$27.5MM
ChimeChime$31.25+17.92%$xx.xxSeries G$24.93B$xx.xx$1.1B
KrakenKraken$24.45+0.08%$xx.xxSeries B$5.52B$xx.xx$52.5MM
Liquid DeathLiquid Death$9.60+0.21%$xx.xxSeries F-1$1.4B$xx.xx$67.61MM
CircleCircle$30.00+17.65%$xx.xxSeries F$8.05B$xx.xx$401MM
NetskopeNetskope$13.00+8.7%$xx.xxSeries H$7.5B$xx.xx$300MM

Updated on: Mar 12, 2025

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

  1. Forge Price™ is a custom data-point calculated and disseminated by Forge Data LLC (“Forge Data”) and is a mark of Forge Data. Forge Price may rely on a very limited number of inputs in its calculation. Forge Price is prepared and disseminated solely for informational purposes. Redistribution is permitted solely with Forge’s written consent. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of Forge Price, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of Forge Price. Forge Price is derived from secondary activity on the Forge platform and other private market trading platforms, and other publicly-available datapoints collected by Forge. Forge Price is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Neither reference to company names, nor calculation of Forge Price for a specific company, implies any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company. The dollar-figure and percentage displayed indicates the per share change in dollar amount and percentage since the most recent Forge Price change. Percentages are rounded to the nearest whole number.
  2. The Last Closed Trade price displayed reflects the price at which the last trade in this company's security occurred on Forge, and can include secondary trades in any class of the company's security, or trades in units of funds holding the company's securities (the economics of which differ versus direct company ownership). The date displayed reflects the date on which the last trade in this company's security closed on Forge. This may be several weeks after the terms of the trade were agreed upon between the buyer and seller. In case of multiple trades closed on the same date, the price displayed is of either (i) the trade which terms were agreed upon most recently; or (ii) the trade with the higher notional value.
  3. Post-Money Valuation represents the estimated valuation based on company-submitted Certificates of Incorporations (COIs).
  4. Last Known Valuation represents a valuation gathered from non-COI, publicly available sources including company press releases or multiple concurring news articles.
  5. The dollar-figure and percentage displayed indicates the per share change in dollar amount and percentage since the most recent Forge Price change. Percentages are rounded to the nearest whole number.

‘Stock Price’ or other private company metrics (‘PC Data’) may rely on a very limited number of trade and/or IOI inputs in their calculation. PC Data is prepared and disseminated solely for informational purposes. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of PC Data, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of PC Data. PC Data is derived from the performance and pricing of secondary activity on the Forge platform and other private market trading platforms. PC Data is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Reference to company names does not imply any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company.

The news articles displayed on this page may be curated using artificial intelligence (AI) technology, which selects relevant content from a list of trusted web sources. While we strive for accuracy and reliability, the inclusion of an article does not imply endorsement or verification of its content. This communication is for informational purposes only. Investors should conduct their own research and consult a financial professional before making investment decisions.

Investing in private company securities is not suitable for all investors, is highly speculative, is high risk, and investors should be prepared to withstand a total loss of their investment. Private company securities are highly illiquid and there is no guarantee that a market will develop for such securities. Each investment carries its own risks, and investors should conduct their own due diligence regarding the investment, including obtaining independent professional advice. Past performance is not indicative of future results. This is not a recommendation, offer, solicitation of an offer, or advice to buy or sell securities by Forge, nor an offer of brokerage services in any jurisdiction where Forge is not permitted to offer brokerage services. Brokerage products and services are offered by Forge Securities LLC, a registered broker-dealer and member FINRA/SIPC. Please see other important disclaimers, disclosures and restrictions you acknowledge by using this website and to which you are subject.